NATCO PHARMA
|
The Current P/S Ratio of NATCO PHARMA is 4.21.
| Share Price | ₹819.0 | Sep 10,2026 |
| Market Cap | ₹14,668.3 Cr | |
| Sales-TTM | ₹3,484.6 Cr | TTM-Consolidated Results |
| Price/Sales | 4.21x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of NATCO PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹14,668.3 Cr] as on Sep 10,2026
(/) Sales [ ₹3,484.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.21x ]
Thus, for NATCO PHARMA , the investors are currently willing to pay '4.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NATCO PHARMA !
The chart below summarizes the trend in P/S Ratio of NATCO PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of NATCO PHARMA
PS Ratio Performance Analysis for NATCO PHARMA
- NATCO PHARMA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 4.53x.
- NATCO PHARMA 's operated at median p/e ratio of 4.26x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NATCO PHARMA 's p/e ratio peaked in Mar2022 at 7.11x.
- NATCO PHARMA 's p/e ratio hit its five-year low in Mar2025 of 3.22x.
How does NATCO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| NATCO PHARMA | 3,484.6 | 4.21 | 14,668.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.47 | 447,236.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.23 | 249,673.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.92 | 187,460.0 |
| CIPLA LTD | 28,324.4 | 3.94 | 111,484.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.87 | 95,220.3 |
| MANKIND PHARMA LTD | 14,737.9 | 6.29 | 92,769.9 |
| LUPIN LTD | 29,966.6 | 3.17 | 94,882.7 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.90 | 111,521.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.75 | 96,030.6 |
| LAURUS LABS LTD | 7,269.6 | 14.39 | 104,604.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NATCO PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.75x |
| Max industry PS | 22.23x |
| Median industry PS | 4.21x |
| Average industry PS | 7.56x |
You may also like the below Video Courses